Compare IOT & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOT | ZBH |
|---|---|---|
| Founded | 2015 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 19.5B |
| IPO Year | 2021 | 2001 |
| Metric | IOT | ZBH |
|---|---|---|
| Price | $28.27 | $83.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 21 |
| Target Price | $45.42 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 5.1M | 2.5M |
| Earning Date | 06-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | ★ 92.86 | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | $1,618,635,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $23.00 | $4.96 |
| Revenue Next Year | $19.69 | $3.76 |
| P/E Ratio | ★ N/A | $65.44 |
| Revenue Growth | ★ 29.57 | 7.20 |
| 52 Week Low | $23.38 | $79.12 |
| 52 Week High | $48.41 | $108.29 |
| Indicator | IOT | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 42.77 | 42.08 |
| Support Level | $28.04 | $79.83 |
| Resistance Level | $28.28 | $96.69 |
| Average True Range (ATR) | 1.38 | 2.62 |
| MACD | -0.09 | -0.43 |
| Stochastic Oscillator | 5.74 | 30.70 |
Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers range from small and medium-sized businesses to state and local governments.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.